Market Research Logo

Genera Biosystems Ltd (GBI) - Product Pipeline Analysis, 2017 Update

Summary

Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is a molecular diagnostic test for the detection and genotyping of high risk and low risk types of human papillomavirus that cause cervical cancer or genital warts. GBL uses AmpaSand beads technology to create identifiable clusters of beads which can be distinguished in a conventional flow cytometer. The company provides products to detect influenzaA, influenzaB, influenza A H1N1, influenzaA H5N1, respiratory syncytial virus, human metapneumovirus, adenovirus, rhinovirus, bordetella pertussis, and chlamydophila pneumonia. It collaborates with pathology customers and IVD companies. GBL is headquartered in Melbourne, Victoria, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Genera Biosystems Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Genera Biosystems Ltd Company Overview
Genera Biosystems Ltd Company Snapshot
Genera Biosystems Ltd Pipeline Products and Ongoing Clinical Trials Overview
Genera Biosystems Ltd – Pipeline Analysis Overview
Genera Biosystems Ltd - Key Facts
Genera Biosystems Ltd - Major Products and Services
Genera Biosystems Ltd Pipeline Products by Development Stage
Genera Biosystems Ltd Ongoing Clinical Trials by Trial Status
Genera Biosystems Ltd Pipeline Products Overview
BBVplex
BBVplex Product Overview
Diagnostic Test- Hepatitis B/C
Diagnostic Test- Hepatitis B/C Product Overview
Diagnostic Test- Herpes Simplex Virus (HSV) 1 / HSV 2
Diagnostic Test- Herpes Simplex Virus (HSV) 1 / HSV 2 Product Overview
Gen-plex
Gen-plex Product Overview
Gen-plex Clinical Trial
PapType
PapType Product Overview
PapType Clinical Trial
PapType SP
PapType SP Product Overview
QSand Platform
QSand Platform Product Overview
STIplex
STIplex Product Overview
Genera Biosystems Ltd - Key Competitors
Genera Biosystems Ltd - Key Employees
Genera Biosystems Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Genera Biosystems Ltd, Recent Developments
Nov 15, 2016: Genera Lodges 2016 Tax Return - To Receive $752k R&D Tax Rebate
Oct 03, 2016: Genera Biosystems: 2016 Annual Report Highlights
Oct 03, 2016: Genera Biosystems Limited Receipt Of Data For Paptype 2,000 Specimens In US Based Screening Population
Jun 21, 2016: Genera Biosystems provides update on PapType HPV test
Jun 21, 2016: Genera Biosystems Receives Regulatory Approval For Its Multiplex Molecular Diagnostics Test RTI-plex
Aug 07, 2015: Genera Biosystems: Receipt Of Predictors 3 Clinical Data
Sep 03, 2014: Genera Biosystems provides update on multiplex diagnostic assay STIplex
Sep 03, 2014: Genera Biosystems to Submit TGA Application for Conformity Assesment for Multiplex Molecular Diagnostics Test RTI-Plex
Sep 03, 2014: Genera Lodges TGA Application For Conformity Assesment for PapType HPV assay
Apr 29, 2014: Genera Biosystems Welcomes Australian MSAC Recommendation For Hpv Testing As Primary Cervical Cancer Screening Tool
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Genera Biosystems Ltd Pipeline Products and Ongoing Clinical Trials Overview
Genera Biosystems Ltd Pipeline Products by Equipment Type
Genera Biosystems Ltd Pipeline Products by Indication
Genera Biosystems Ltd Ongoing Clinical Trials by Trial Status
Genera Biosystems Ltd, Key Facts
Genera Biosystems Ltd, Major Products and Services
Genera Biosystems Ltd Number of Pipeline Products by Development Stage
Genera Biosystems Ltd Pipeline Products Summary by Development Stage
Genera Biosystems Ltd Ongoing Clinical Trials by Trial Status
Genera Biosystems Ltd Ongoing Clinical Trials Summary
BBVplex - Product Status
BBVplex - Product Description
Diagnostic Test- Hepatitis B/C - Product Status
Diagnostic Test- Hepatitis B/C - Product Description
Diagnostic Test- Herpes Simplex Virus (HSV) 1 / HSV 2 - Product Status
Diagnostic Test- Herpes Simplex Virus (HSV) 1 / HSV 2 - Product Description
Gen-plex - Product Status
Gen-plex - Product Description
Gen-plex - Predictors 3 Study
PapType - Product Status
PapType - Product Description
PapType - Predictors 3 Study
PapType SP - Product Status
PapType SP - Product Description
QSand Platform - Product Status
QSand Platform - Product Description
STIplex - Product Status
STIplex - Product Description
Genera Biosystems Ltd, Key Employees
Glossary
List of Figures
Genera Biosystems Ltd Pipeline Products by Equipment Type
Genera Biosystems Ltd Pipeline Products by Development Stage
Genera Biosystems Ltd Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report